{"id":213,"date":"2018-05-28T09:55:14","date_gmt":"2018-05-28T00:55:14","guid":{"rendered":"http:\/\/www.medphas.kumamoto-u.ac.jp\/cmha\/?post_type=e_news&amp;p=213"},"modified":"2018-05-28T09:55:14","modified_gmt":"2018-05-28T00:55:14","slug":"2018082302-2","status":"publish","type":"e_news","link":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/e_news\/2018082302-2\/","title":{"rendered":"The collaborative work by Dana-Farber Cancer Institute and Prof. Hideo BABA is published in Nature Medicine."},"content":{"rendered":"<p>Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.<\/p>\n<p>&nbsp;<\/p>\n<p>Wong GS, Zhou J, Liu JB, Wu Z, Xu X, Li T, Xu D, Schumacher SE, Puschhof J, McFarland J, Zou C, Dulak A, Henderson L, Xu P, O&#8217;Day E, Rendak R, Liao WL, Cecchi F, Hembrough T, Schwartz S, Szeto C, Rustgi AK, Wong KK, Diehl JA, Jensen K, Graziano F, Ruzzo A, Fereshetian S, Mertins P, Carr SA, Beroukhim R, Nakamura K, Oki E, Watanabe M, Baba H, Imamura Y, Catenacci D, Bass AJ<\/p>\n<p>&nbsp;<\/p>\n<p><strong><em>Nat Med<\/em><\/strong> 24(7):968-977, 2018.<\/p>\n<p>&nbsp;<\/p>\n<p>Click <a href=\"https:\/\/www.nature.com\/articles\/s41591-018-0022-x\">HERE<\/a> for journal.<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","class_list":["post-213","e_news","type-e_news","status-publish","hentry","e_category-researches"],"_links":{"self":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/e_news\/213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/e_news"}],"about":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/types\/e_news"}],"wp:attachment":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/media?parent=213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}